ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Latest Statistics Show Decline In Deaths From Breast Cancer

January 13, 1995

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

DCT Board Okays Concepts For New Trials In Imaging, Intraoperative RT

June 14, 1985

FDA Approves Abbott’s HER-2 DNA Probe Kit.

January 25, 2002